ACC 2024 Hybrid Group Meetings

Sunday,  April 7,  Guidepoint Insights will be hosting a series of group meetings featuring KOLs who will dive deeper into ACC 2024 updates.

    Sunday, April 7th
    8:00 AM ET - Ahmad Masri
    • Hypertrophic Cardiomyopathy, Cytokinetics (SEQUIOA Data) | Director of Hypertrophic Cardiomyopathy and Amyloidosis Centers, Oregon Health & Science University
    9:00 AM ET - John Ryan
    • Hypertension, Alnylam/Roche Vutrisiran KARDIA-2 Data | Associate Professor, Chief of General Cardiology, The University of Utah
    10:00 AM ET - Carlos Garcia Santos-Gallego
    • Pfizer, Alnylam, BridgeBio, Transthyretin Cardiomyopathy | Cardiologist, The Mount Sinai Hospital
    12:00 PM ET - Ronald H Wharton
    • Hypertrophic Cardiomyopathy, Cytokinetics (SEQUIOA Data) | Cardiologist, North Shore University Hospital
    1:00 PM ET - Martin Maron
    • Hypertrophic Cardiomyopathy, Cytokinetics (SEQUIOA Data) | Medical Director, HCM Center, Lahey Hospital & Medical Center
    2:00 PM ET - James Underberg
    • Lipidology, New Amsterdam, Novartis (inclisiran), Esperion | President, Foundation of the National Lipid Association

    *ACC Group Meetings will be 50 minutes long and available only to attendees. Group meetings are not recorded and transcripts will not be available following the event.